Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Diabetes Experts Explore Pros And Cons Of Developing Mobile Health Apps

This article was originally published in The Gray Sheet

Executive Summary

Mobile health developers looking to enter the diabetes care space face significant challenges, but also have a unique opportunity to address critical user needs, experts said recently.

You may also be interested in...

Research In Brief

Assessing early AF intervention

Industry Applauds FDA Draft Guidance On Mobile Medical Apps

The medical device and software industries voiced support last week for a July 19 FDA draft guidance that helps clarify the types of mobile software applications that would face FDA regulation.

Cloud Computing Could Complicate Efforts To Clarify Mobile Health Regulation

Advances in cloud computing – where data storage or processing tasks for a software application are distributed among multiple remote computer networks – are adding a new wrinkle to industry’s efforts to draft a mobile health regulatory guidance document for FDA review.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts